<DOC>
	<DOCNO>NCT02389790</DOCNO>
	<brief_summary>The primary objective study : -To evaluate long-term safety tolerability MT-1303 subject moderate severe active Crohn 's Disease（CD）</brief_summary>
	<brief_title>Extension Study MT-1303 Subjects With Crohn 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>The subject complete 14 week Treatment Period double blind MT1303E13 study per Protocol . Permanent discontinuation study medication prior end treatment Visit MT1303E13</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Crohn 's Disease</keyword>
</DOC>